Awak, a Singaporean medtech firm has raised $20 million in series B funding. Jointly led by Lion X Ventures and Vickers Venture, the round witnessed participation from Advanced MedTech and Eckuity Capital. The firm plans to use its series B funds to complete its ongoing pre-pivotal clinical trial and enhance its on-the-go kidney dialysis machines.
_
This article has been summarised for a quick read. You can find the original article on Tech in Asia.